China's Health Care Market Draws Healthy Investment
This article was originally published in PharmAsia News
Hospital investment and management firm Hua Xia Healthcare Holdings announced that it has put aside funds to acquire 10 private hospitals this year. The company spoke to more than 100 international health care investment organizations in 2007 and found that at least $60 billion capital has been earmarked for China. International Finance Corp., a member of World Bank Group, estimated it invested $700 million in China's hospitals last year. Four health-related enterprises, including Fosun Pharma, received loan support totaling $870 million. Eplanet Ventures plans to complete its second round of fund raising that invests mainly in the health care market in India and China. Domestic investors also see China's market opportunities; Shunde private capitalists have funded an 800 million yuan private hospital that began construction in Guangdong last year. (Click here for more - Chinese Language)
You may also be interested in...
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.